Cancerous Adaptive Dosing Melanoma WGS Dataset
Illumina NovaSeq 6000 30x WGS of 26 samples, each with up to 5 matched timepoints. Timepoints A,B,C,D,and E correspond to Pretreatment, Week 3, Week 6, Week 9, and Week 12 after treatment, respectively. Additional sample metadata (sample recurrence, treatment course, age, sex, comorbidities, etc.) are present in sample description.
- 282 samples
- DAC: EGAC00001003271
- Technologies: Illumina HiSeq 4000, Illumina NovaSeq 6000
Data will be made available to any bona fide researcher employed at a company or institution of good standing, subject to US data export laws and regulations, who agrees to the data access agreement and intends to use the Data to interpret, verify, or extend the research in the article in which the Data were first published.
Data will be made available to any bona fide researcher employed at a company or institution of good standing, subject to US data export laws and regulations, who agrees to the data access agreement and intends to use the Data to interpret, verify, or extend the research in the article in which the Data were first published. The data access agreement forbids licensing or sale of Data or the offering of a service or other product using Data, including any larger set into which Data has been incorporated.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |